Downregulated expression of PRMT-induced G1–S arrest indicated that suppression of PRMT5 inhibited laryngeal carcinoma proliferation by arresting the cell cycle in the G1 phase (Fig. 2g). Here, PRMT5 is linked to laryngeal carcinoma.